News Feed

Creatine, a popular supplement known for improving muscle strength and athletic performance, may also have potential as a treatment for depression. A recent review analyzed five randomized clinical trials involving 238 participants to evaluate its effects on mental health. While two studies involving women with major depressive disorder found that creatine enhanced the benefits of standard antidepressant treatment, three other trials showed no significant improvement. Researchers believe creatine may support brain function by increasing cellular energy, but the current evidence remains mixed. Larger, well-designed clinical trials are needed before creatine can be recommended as a routine treatment for depression.

Researchers have identified a potential mechanism that may explain how Alzheimer’s disease spreads through the brain. The study suggests that a common brain protein may transport toxic Tau proteins from damaged neurons to healthy ones, allowing the disease to progressively affect new brain regions. By blocking these harmful protein-containing packages before they enter healthy cells, scientists believe it may be possible to slow or even halt the progression of Alzheimer's. While the findings are still in the research stage and require further validation, they offer a promising new target for developing future treatments aimed at delaying disease progression rather than simply managing symptoms.

Researchers have identified how individual brain cells work together to produce human speech by combining single-cell brain recordings with artificial intelligence. Using data from epilepsy patients with implanted microelectrode arrays, scientists discovered that specific neurons process different aspects of language—from the meaning of words to sentence structure and context. Remarkably, brain activity recorded just before speaking accurately predicted the words participants were about to say. These findings provide the most detailed view yet of how the brain encodes language and could pave the way for advanced brain-computer interfaces that convert neural activity into speech, offering new hope for people with paralysis or communication disorders.

A groundbreaking first-in-human clinical trial has shown promising results for a new treatment targeting retinitis pigmentosa, a leading cause of inherited blindness. Researchers found that a photoswitch molecule injected into the eye reactivated damaged retinal cells, allowing them to respond to light even after normal light-sensing cells were lost. The treatment was well tolerated, with no serious side effects, and some participants experienced improved light perception and better performance in visual tasks. Unlike gene therapies, this approach could work across multiple forms of retinal degeneration without genetic modification. While the findings are preliminary, a larger Phase 2 trial is already underway to evaluate its effectiveness.

Scientists have developed a promising vitamin B12–based compound that could improve treatment for glioblastoma, one of the deadliest forms of brain cancer. In preclinical animal studies, the compound successfully crossed the blood-brain barrier and selectively accumulated inside glioblastoma tumors. It then released sustained levels of nitric oxide directly into cancer cells, helping to slow tumor growth. When combined with existing glioblastoma therapies, the treatment showed a powerful synergistic effect, significantly boosting anti-tumor activity compared to standard treatments alone. Although these findings are still limited to animal studies, they highlight a potential new strategy for delivering targeted therapies to hard-to-treat brain cancers.

A new review suggests that gut microbes play a much larger role in hormone-driven cancers than previously thought. Scientists found that the gut microbiome can influence estrogen levels by producing hormone-like compounds, regulating inflammation, and modifying hormone metabolism. These interactions may affect the development of estrogen-related cancers such as breast and endometrial cancer. Researchers are also exploring microbiome-based therapies, including probiotics, prebiotics, live biotherapeutics, and fecal microbiota transplantation, as potential treatment strategies. However, current evidence is largely based on laboratory and observational studies. Larger clinical trials are needed before these approaches can become part of routine cancer prevention or personalized treatment.

A quick 13-second eye test could help doctors predict whether patients with severe brain injuries are likely to regain consciousness. Researchers found that a little-known part of the pupil's response to light, called the late light-off response (LOR), was linked to improvements in consciousness seven days later. In contrast, standard ICU pupil tests failed to predict recovery. The study analyzed 250 patients with traumatic and non-traumatic brain injuries and suggests that this simple bedside test may reveal the brain's recovery potential before clinical signs appear. Although larger studies are still needed, this promising approach could improve patient monitoring and guide treatment decisions in intensive care units.

A major international MRI study analyzing brain scans from over 12,000 individuals has identified subtle brain structure changes associated with major depressive disorder (MDD). Researchers found that people with depression had thinner cortical regions involved in emotion regulation, decision-making, attention, and movement, while overall brain surface area remained unchanged. These differences were most evident in adults experiencing active depression, but not in adolescents. The study also observed slightly greater cortical thinning in patients taking antidepressants, though the effects were modest. While these findings are not yet suitable for diagnosis, they provide valuable insights into depression's biological basis and may help develop better diagnostic tools and personalized treatments in the future.

Scratching an itchy bug bite may feel satisfying, but science shows it can actually make the problem worse. Researchers found that scratching activates immune cells called mast cells, increasing inflammation, swelling, and itchiness. It also triggers the release of a chemical messenger that amplifies the body's inflammatory response, creating a frustrating itch-scratch cycle. While scratching may provide brief relief and even help remove some germs from the skin, the overall effect is more irritation and a longer-lasting itch. Experts recommend using anti-itch creams, calamine lotion, hydrocortisone, or menthol-based products instead. Resisting the urge to scratch can help your skin heal faster and reduce discomfort.

Once reserved for elite athletes, ice baths have become a global wellness trend embraced by fitness enthusiasts and social media influencers alike. Research suggests that cold-water immersion may help reduce post-workout muscle soreness, lower stress levels, and improve sleep quality in the short term. However, experts caution that popular claims about boosting immunity or extending lifespan are not yet backed by strong scientific evidence. Beyond the physical benefits, many people view cold plunges as a way to build mental resilience and discipline by stepping outside their comfort zone. While more research is needed, cold therapy continues to gain popularity as a recovery and wellness practice.